Medline (MDLN) Accumulated Expenses (2024 - 2026)

Medline (MDLN) has reported Accumulated Expenses for 3 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses changed N/A year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (changed N/A YoY), while the FY2025 annual figure was $1.5 billion, down 2.75% from the prior year.
• Accumulated Expenses improved to $1.5 billion in Q1 2026 per MDLN's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.5 billion in Q1 2026 and bottomed at $1.5 billion in Q4 2025.
• Historically, Accumulated Expenses has averaged $1.5 billion across 3 years, with a median of $1.5 billion in 2024.
• On a YoY basis, Accumulated Expenses climbed as much as 2.75% in 2025 and fell as far as 2.75% in 2025.
• Medline's Accumulated Expenses stood at $1.5 billion in 2024, then dropped by 2.75% to $1.5 billion in 2025, then increased by 5.17% to $1.5 billion in 2026.
• Business Quant data shows MDLN's Accumulated Expenses at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q4 2024.